“…CRISPR and CRISPRi have been individually harnessed to engineer genome or rewire metabolic networks in different bacteria such as cyanobacteria (Huang et al, ) and E. coli (Y. Li et al, ) to promote the production of bio‐derived chemicals. However, virtually all previous studies exploiting CRISPR or CRISPRi for E. coli engineering have used SpCas9 (Ding, Weng, Du, Chen, & Kang, ; Heo et al, ; Y. Jiang et al, ; Kiani et al, ; Liang et al, ; Liu et al; Pyne, Moo‐Young, Chung, & Chou, ; Reisch & Prather, ; Ronda, Pedersen, Sommer, & Nielsen, ; Umenhoffer et al, ; Zhao et al, ) or SpdCas9 (Cress et al, , ; Kim et al, ; S. Li, Jendresen, et al, ; Lv et al, ; Rath, Amlinger, Hoekzema, Devulapally, & Lundgren, ; Wu et al, ). Furthermore, in previous studies the CRISPRi modules were maintained in plasmids and have yet to be integrated into the chromosome using the CRISPR system, which is at least partly because the expressed SpCas9 may complex with the sgRNA designed for SpdCas9‐mediated suppression and lead to off‐target mutagenesis.…”